T&R Biofab Co., Ltd. (246710.KQ)
KRW 4920.0
(-4.65%)
KRW 4920.0
(-4.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -6.96 Billion | -5.88 Billion | -7.56 Billion | -8.37 Billion | -5.17 Billion |
| Net Income | -13.41 Billion | -10.33 Billion | -70.06 Billion | -5.6 Billion | -6.25 Billion |
| Depreciation & Amortization | 2.15 Billion | 1.94 Billion | 1.74 Billion | 1.26 Billion | 814.37 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 1.34 Billion | 3.62 Billion | 722.1 Million | 435.02 Million | 88.84 Million |
| Change in working capital | 114.6 Million | -593.63 Million | -698.02 Million | -5.08 Billion | 1.28 Billion |
| Other non-cash items | 5.9 Billion | 195.41 Million | 75.46 Billion | -209.43 Million | -1.1 Billion |
| Investing Cash Flow | -37.51 Billion | 17.57 Billion | -33.77 Billion | 1.02 Billion | -270.89 Million |
| Investments in PPE | -12.72 Billion | -11.03 Billion | -9.03 Billion | -2.16 Billion | -668.04 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -64.48 Billion | -75.6 Billion | -51.43 Billion | -25.2 Billion | - |
| Sales/Maturities of investments | 39.48 Billion | 104.02 Billion | 28.34 Billion | 28.5 Billion | - |
| Other Investing Activities | 216.95 Million | 163.28 Million | -1.65 Billion | -108.05 Million | 397.15 Million |
| Financing Cash Flow | 29.58 Billion | -219.46 Million | 41.65 Billion | 26.03 Billion | 511.51 Million |
| Debt repayment | -28.5 Billion | -890.05 Million | -41.2 Billion | -487.03 Million | -411.62 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 2.02 Billion | 587.35 Million | 1.04 Billion | 479.32 Million | - |
| Other Financing Activities | 38.41 Million | 83.23 Million | 123.64 Million | 52.43 Million | 923.14 Million |
| Accounts receivables | -843.52 Million | -507.95 Million | -513.5 Million | -407.14 Million | 9.69 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | 361.88 Million | 635.9 Million | 103.41 Million | -3.15 Billion | -33.06 Million |
| Other working capital | 597.42 Million | -736.07 Million | -284.84 Million | -1.45 Billion | 1.3 Billion |
| Cash at beginning of period | 35.12 Billion | 23.66 Billion | 23.27 Billion | 4.72 Billion | 9.65 Billion |
| Cash at end of period | 20.22 Billion | 35.12 Billion | 23.66 Billion | 23.27 Billion | 4.72 Billion |
| Capital Expenditure | -12.72 Billion | -11.03 Billion | -9.03 Billion | -2.16 Billion | -668.04 Million |
| Effect of forex changes on cash | -252.51 Thousand | -14.26 Million | 68.76 Million | -132.58 Million | - |
| Net cash flow / Change in cash | -14.89 Billion | 11.45 Billion | 385.93 Million | 18.55 Billion | -4.93 Billion |
| Free Cash Flow | -19.69 Billion | -16.92 Billion | -16.6 Billion | -10.53 Billion | -5.84 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -955.77 Million | -7.74 Billion | -271.33 Million | -13.41 Billion | -5.39 Billion | -4.07 Billion |
| Depreciation & Amortization | 625.27 Million | 610.38 Million | 583.36 Million | 2.15 Billion | 557.93 Million | 546.89 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 69.76 Million | 332.45 Million | 314.75 Million | 1.34 Billion | 341.75 Million | 348.05 Million |
| Change in working capital | -148.97 Million | -957.8 Million | 94.93 Million | 114.6 Million | 384.59 Million | -983.02 Million |
| Other non-cash items | -1.69 Billion | 4.34 Billion | 1.17 Billion | 5.9 Billion | 2.25 Billion | 1.27 Billion |
| Investing Cash Flow | 1.48 Billion | 10.15 Billion | 8.9 Billion | -37.51 Billion | -25.87 Billion | -6.56 Billion |
| Investments in PPE | -993.5 Million | -1.01 Billion | -1.16 Billion | -12.72 Billion | -2.91 Billion | -4.25 Billion |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -5.92 Billion | -5.49 Billion | -64.48 Billion | -44 Billion | -2.99 Billion |
| Sales/Maturities of investments | - | 17.06 Billion | 15.37 Billion | 39.48 Billion | 21 Billion | 601.82 Million |
| Other Investing Activities | 2.48 Billion | 12.71 Million | 188.48 Million | 216.95 Million | 38.86 Million | 79.01 Million |
| Financing Cash Flow | -2.07 Billion | -17.63 Billion | -784.39 Million | 29.58 Billion | 30.7 Billion | -163.77 Million |
| Debt repayment | -2.16 Billion | -17.4 Billion | -5.5 Billion | -28.5 Billion | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2 Billion | 2.02 Billion | - | - |
| Other Financing Activities | 85.85 Million | 25.13 Million | 2.96 Billion | 38.41 Million | -3.05 Billion | 87.3 Million |
| Accounts receivables | 234.26 Million | -888.95 Million | -338.59 Million | -843.52 Million | -124.46 Million | 316.56 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -53.63 Million | 269.85 Thousand | 779.44 Million | 361.88 Million | -433.28 Million | -168.43 Million |
| Other working capital | -329.61 Million | -61.19 Million | -345.91 Million | 597.42 Million | 1.06 Billion | -1.2 Billion |
| Cash at beginning of period | 9.07 Billion | 20.22 Billion | 14.38 Billion | 35.12 Billion | 10.79 Billion | 20.12 Billion |
| Cash at end of period | 6.38 Billion | 9.07 Billion | 20.22 Billion | 20.22 Billion | 14.38 Billion | 10.79 Billion |
| Capital Expenditure | -993.5 Million | -1.01 Billion | -1.16 Billion | -12.72 Billion | -2.91 Billion | -4.25 Billion |
| Effect of forex changes on cash | -27.9 Thousand | - | -252.51 Thousand | -252.51 Thousand | 2.78 Million | -2.78 Million |
| Net cash flow / Change in cash | -2.69 Billion | -11.15 Billion | 5.83 Billion | -14.89 Billion | 3.59 Billion | -9.32 Billion |
| Free Cash Flow | -3.09 Billion | -4.68 Billion | -3.45 Billion | -19.69 Billion | -4.15 Billion | -6.85 Billion |
BC-PA
GFPT
NEM
2086
6682
TES